Keene Brandon A.

Chief Innovation Officer at BLDE

Sold, on record
$384k
Dollars the filings state
Form 4 sales
3
Latest Nov 18, 2022
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • BLDEStrata Critical Medical, Inc.Chief Innovation Officer

Sales by reason

0
Routine
3
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Timeline

  1. 1 Form 4 sale BLDEPlan not stated
    Sep 14, 2022 2022

    Sold 50,000 shares at $4.79 ($239k)

    Keene Brandon A., Chief Innovation Officer

    Sold 12.5% of holdings ($1.9M position)348,975 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale BLDEPlan not stated
    Oct 6, 2022 +22 days

    Sold 1,283 shares at $3.97 ($5k)

    Keene Brandon A., Chief Innovation Officer

    Sold 0.4% of holdings ($1.4M position)347,692 shares leftFiling

  3. 3 Form 4 sale BLDEPlan not stated
    Nov 18, 2022 +43 days

    Sold 29,103 shares at $4.79 ($139k)

    Keene Brandon A., Chief Innovation Officer

    Sold 8.4% of holdings ($1.7M position)318,589 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Keene Brandon A.
Source
Nov 18, 2022Nov 21, 2022BLDEChief Innovation OfficerForm 4 sale29,103$139k8.4%Plan not statedSEC
Oct 6, 2022Oct 11, 2022BLDEChief Innovation OfficerForm 4 sale1,283$5k0.4%Plan not statedSEC
Sep 14, 2022Sep 14, 2022BLDEChief Innovation OfficerForm 4 sale50,000$239k12.5%Plan not statedSEC